Millions of people worldwide are affected by African sleeping sickness, Chagas disease and other life-threatening infections ...
Hosted on MSN11mon
Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock RalliesIn July 2023, PaxMedica released topline data from PAX-HAT-301 Retrospective Analysis of Suramin Treatment for Stage 1 Trypanosoma Brucei Rhodesiense Human African Trypanosomiasis (S1 TBR HAT).
A new study by LMU and Helmholtz Munich shows how the pathogen Trypanosoma brucei controls changes in its cell surface to evade the immune ...
München (ots) - - Eine neue Studie von LMU und Helmholtz Munich zeigt, wie der Krankheitserreger Trypanosoma brucei die Veränderung seiner Zelloberfläche steuert, um ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results